Clinical Trials Browser

Essential Hypertension × Clear all

NCT01022515 2026-02-06

PHEO

Phase NA Completed

Essential Hypertension, Hypertension, Paraganglioma, Pheochromocytoma

NCT07375407 2026-02-02

Aerobic Exercise vs Physiological Ischemic Training in Stage 2 Hypertension

Phase NA Completed

Essential Hypertension, Lymphoma, Follicular

NCT05972785 2024-08-21

Long-term Use of CCB and Breast Cancer Risk

Active not recruiting

68,500 enrolled

Essential Hypertension, Breast Neoplasms

NCT05638269 2024-07-29

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

12,000 enrolled

GastrointestinalHead & NeckThoracic

Essential Hypertension, Cardiovascular Diseases, Endocrine System Diseases, Epilepsy, Hyperaldosteronism, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Nervous System Diseases, Pancreatic Neoplasms, Stomach Neoplasms, Urologic Diseases, Renal Insufficiency, Chronic, Acute Coronary Syndrome

NCT06500000 2024-07-15

The Plasma Metabolomics Profiling of Primary Aldosteronism

Essential Hypertension, Hyperaldosteronism, Adrenocortical Adenoma

NCT06090617 2024-03-19

WHYSKI

Essential Hypertension, Hyperaldosteronism, Hypertension, Adrenocortical Adenoma

NCT01151410 2016-03-07

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Phase 3 Completed

208 enrolled 10 charts

Essential Hypertension, Hypertension, Neoplasm Metastasis

NCT01629225 2014-11-18

GRK4 Polymorphisms Blood Pressure Response to Candesartan

Phase 4 Unknown

Essential Hypertension, Multiple Endocrine Neoplasia Type 1